{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:05:27Z","timestamp":1762380327653,"version":"build-2065373602"},"reference-count":8,"publisher":"Massachusetts Medical Society","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2025,11,6]]},"DOI":"10.1056\/nejme2512027","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:00:21Z","timestamp":1762380021000},"page":"1854-1855","source":"Crossref","is-referenced-by-count":0,"title":["Oral Psoriasis Therapy \u2014 For Whom and at What Cost and Risk?"],"prefix":"10.1056","volume":"393","author":[{"given":"Robert S.","family":"Stern","sequence":"first","affiliation":[{"name":"Department of Dermatology, Harvard Medical School, Boston"},{"name":"Department of Dermatology, Beth Israel Deaconess Medical Center, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"150","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.2007"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120225"},{"issue":"5","key":"e_1_3_3_4_2","first-page":"CD011535","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.","volume":"5","author":"Sbidian E","year":"2022","unstructured":"Sbidian E, Chaimani A, Garcia-Doval I, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev 2022;5(5):CD011535-CD011535.35603936","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308713"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2504187"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2500155"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119669"},{"key":"e_1_3_3_9_2","unstructured":"Fortune Business Insights. Psoriasis treatment market size share & industry analysis by drug class (TNF inhibitors interleukins inhibitors and others) by type (plaque psoriasis psoriatic arthritis and others) by product type (biologics and non-biologics) by route of administration (oral parenteral\/systemic and topical) by distribution channel (hospital pharmacies retail pharmacies and online pharmacies) and regional forecast 2025\u20132032. September 29 2025 (https:\/\/www.fortunebusinessinsights.com\/industry-reports\/psoriasis-treatment-market-100600)."}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMe2512027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:00:27Z","timestamp":1762380027000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMe2512027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":8,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,11,6]]}},"alternative-id":["10.1056\/NEJMe2512027"],"URL":"https:\/\/doi.org\/10.1056\/nejme2512027","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}